Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria

被引:122
作者
John, Chandy C. [1 ]
Panoskaltsis-Mortari, Angela [1 ]
Opoka, Robert O. [2 ]
Park, Gregory S. [1 ]
Orchard, Paul J. [1 ]
Jurek, Anne M. [1 ]
Idro, Richard [2 ]
Byarugaba, Justus [2 ]
Boivin, Michael J. [3 ]
机构
[1] Univ Minnesota, Dept Pediat, Global Pediat Program, Minneapolis, MN 55455 USA
[2] Makerere Univ, Dept Paediat & Child Hlth, Mulago Hosp, Kampala, Uganda
[3] Michigan State Univ, Coll Osteopath Med, INPEP, E Lansing, MI 48824 USA
关键词
D O I
10.4269/ajtmh.2008.78.198
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cerebrospinal fluid (CSF) and serum levels of 12 cytokines or chemokines important in central nervous system (CNS) infections were measured in 76 Ugandan children with cerebral malaria (CM) and 8 control children. As compared with control children, children with cerebral malaria had higher cerebrospinal fluid levels of interleukin (IL)-6, CXCL-8/IL-8, granulocyte-colony stimulating factor (G-CSF), tumor necrosis factor-alpha (TNF-alpha), and IL-1 receptor antagonist. There was no correlation between cerebrospinal and serum cytokine levels for any cytokine except G-CSF. Elevated cerebrospinal fluid but not serum TNF-a. levels on admission were associated with an increased risk of neurologic deficits 3 months later (odds ratio 1.55, 95% CI: 1.10, 2.18, P = 0.01) and correlated negatively with age-adjusted scores for attention (Spearman rho, -0.34, P = 0.04) and working memory (Spearman rho, -0.32, P = 0.06) 6 months later. In children with cerebral malaria, central nervous system TNF-alpha production is associated with subsequent neurologic and cognitive morbidity.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 68 条
[1]   Breaking down the blood-brain barrier: signaling a path to cerebral malaria? [J].
Adams, S ;
Brown, H ;
Turner, G .
TRENDS IN PARASITOLOGY, 2002, 18 (08) :360-366
[2]  
ALOISI F, 1992, J IMMUNOL, V149, P2358
[3]   High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria [J].
Armah, H ;
Dodoo, AK ;
Wiredu, EK ;
Stiles, JK ;
Adjei, AA ;
Gyasi, RK ;
Tettey, Y .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2005, 99 (07) :629-647
[4]  
Babcock AA, 2003, J NEUROSCI, V23, P7922
[5]  
Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
[6]   Cognitive impairment after cerebral malaria in children: A prospective study [J].
Boivin, Michael J. ;
Bangirana, Paul ;
Byarugaba, Justus ;
Opoka, Robert O. ;
Idro, Richard ;
Jurek, Anne M. ;
John, Chandy C. .
PEDIATRICS, 2007, 119 (02) :E360-E366
[7]  
Brown H, 1999, NEUROPATH APPL NEURO, V25, P331
[8]   Cytokine expression in the brain in human cerebral malaria [J].
Brown, H ;
Turner, G ;
Rogerson, S ;
Tembo, M ;
Mwenechanya, J ;
Molyneux, M ;
Taylor, T .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1742-1746
[9]   Blood-brain barrier function in cerebral malaria in Malawian children [J].
Brown, H ;
Rogerson, S ;
Taylor, T ;
Tembo, M ;
Mwenechanya, J ;
Molyneux, M ;
Turner, G .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 64 (3-4) :207-213
[10]   TUMOR-NECROSIS-FACTOR-ALPHA MEDIATES THE RELEASE OF BIOACTIVE TRANSFORMING GROWTH-FACTOR-BETA IN MURINE MICROGLIAL CELL-CULTURES [J].
CHAO, CC ;
HU, SX ;
SHENG, WS ;
TSANG, M ;
PETERSON, PK .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 77 (03) :358-365